SPR webinar

Label-free techniques for Drug Discovery:

This webinar took place on August 13th 2018

Register to download slides & media

Please fill out the form to stream our webinar
"Label-free techniques for Drug Discovery: Surface Plasmon Resonance (SPR) and MALDI Mass Spectrometry for Primary (HTS) and Secondary Screening"

I want Bruker to inform me about the latest product news, applications, and events.: *



Bruker is committed to keeping its customers informed and would like to share news of our exclusive events, webinars and product/application updates with you. Please view our updated Privacy and Cookie Policy.




Surface Plasmon Resonance (SPR) and MALDI Mass Spectrometry for Primary (HTS) and Secondary Screening

Webinar Overview

The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32. Beside technical details explaining the latest developments, synergies between MALDI mass spectrometry and SPR will be discussed.

Key Topics

  • Primary and Secondary Screening in Drug Discovery
  • Label-free technologies to reduce artefacts / importance of controls in SPR experiments
  • Kinetic characterization: Determination of KDon- and KDoff-rates of compounds (SPR)
  • Automation strategies to maximize throughput (SPR and MALDI)


Dr. Meike Hamester
Dr. Meike Hamester
Director Small Molecule Pharma Business
Dr. Meike Hamester studied chemistry at the University of Hamburg, Germany. She worked 18 years in the field of mass spectrometry at Thermo Fisher Scientific. Since 2012 Meike works for BRUKER Daltonik in Bremen.
Dipl.-Ing. Sven Malik
Dipl.-Ing. Sven Malik
Senior Application Specialist
Dipl. -Ing. Sven Malik studied Bioprocess-Engineering at TU Dresden. He worked 8 years in the field of surface plasmon resonance. Since 2012 Sven worked for Sierra Sensors GmbH (now Bruker).